Phase III Study of the Value of Thalidomide Added to Melphalan Plus Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma: The HOVON 49 Study von WIJERMANS, Pierre, SCHAAFSMA, Martijn, SONNEVELD, Pieter, TERMORSHUIZEN, Fabian, AMMERLAAN, Rianne, WITTEBOL, Shulamiet, SINNIGE, Harm, ZWEEGMAN, Sonja, VAN MARWIJK KOOY, Marinus, VAN DER GRIEND, René, LOKHORST, Henk

Volltext

Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progre... von Lokhorst, Henk M, van der Holt, Bronno, Cornelissen, Jan J, Kersten, Marie José, van Oers, Marinus, Raymakers, Reinier, Minnema, Monique C, Zweegman, Sonja, Bos, Gerard, Schaap, Nicolaas, Wittebol, Shulamiet, de Weerdt, Okke, Ammerlaan, Rianne, Sonneveld, Pieter

Volltext

High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of... von Thielen, Noortje, van der Holt, Bronno, Verhoef, Gregor E. G., Ammerlaan, Rianne A. H. M., Sonneveld, Pieter, Janssen, Jeroen J. W. M., Deenik, Wendy, Falkenburg, J. H. Frederik, Kersten, Marie José, Sinnige, Harm A. M., Schipperus, Martin, Schattenberg, Anton, van Marwijk Kooy, Rien, Smit, Willem M., Chu, Isabel W. T., Valk, Peter J. M., Ossenkoppele, Gert J., Cornelissen, Jan J.

Volltext

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multi... von Lokhorst, Henk M., van der Holt, Bronno, Zweegman, Sonja, Vellenga, Edo, Croockewit, Sandra, van Oers, Marinus H., von dem Borne, Peter, Wijermans, Pierre, Schaafsma, Ron, de Weerdt, Okke, Wittebol, Shulamiet, Delforge, Michel, Berenschot, Henriëtte, Bos, Gerard M., Jie, Kon-Siong G., Sinnige, Harm, van Marwijk-Kooy, Marinus, Joosten, Peter, Minnema, Monique C., van Ammerlaan, Rianne, Sonneveld, Pieter

Volltext

Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study von Lokhorst, Henk M., van der Holt, Bronno, Cornelissen, Jan J., Kersten, Marie-José, van Oers, Marinus, Raymakers, Reinier, Minnema, Monique C., Zweegman, Sonja, Janssen, Jeroen J., Zijlmans, Mark, Bos, Gerard, Schaap, Nicolaas, Wittebol, Shulamiet, de Weerdt, Okke, Ammerlaan, Rianne, Sonneveld, Pieter

Volltext

Thalidomide Combined With High Dose Melphalan Improves Event Free and Overall Survival In Patients With Newly Diagnosed Multiple Myeloma: Extended Follow-Up Of The HOVON-50 Trial von Lokhorst, Henk, Holt, Bronno van der, Zweegman, Sonja, Vellenga, Edo, Croockewit, Sandra, Van Oers, Marinus H.J., dem Borne, Peter von, Wijermans, Pierre W., Schaafsma, M. R, de Weerdt, Okke, Wittebol, Shulamiet, Delforge, Michel, Bos, Gerard M.J., Sinnige, Harm, MarwijkKooy, Marinus, Joosten, Peter, Minnema, Monique C., Ammerlaan, Rianne, Sonneveld, Pieter

Volltext

No Improvement Of Overall Survival After Extended Follow-Up Of Donor Versus No Donor Analysis Of Newly Diagnosed Myeloma Patients Included In The HOVON 50/54 Study von Lokhorst, Henk, Holt, Bronno van der, Cornelissen, Jan, Kersten, Marie José, Van Oers, Marinus H.J., Raymakers, Reinier, Minnema, Monique C., Zweegman, Sonja, Janssen, Jeroen JWM, Zijlmans, Mark, Bos, Gerard M.J., Schaap, Nicolaas PM, de Weerdt, Okke, Wittebol, Shulamiet, Ammerlaan, Rianne, Sonneveld, Pieter

Volltext

Preliminary Results From a Phase III Trial of Imatinib Versus Imatinib in Combination with Cytarabine in Patients with First Chronic Phase Myeloid Leukemia von Thielen, Noortje, van der Holt, Bronno, Cornelissen, Jan J, Ammerlaan, Rianne, Sonneveld, Pieter, Kersten, Marie José, Falkenburg, J.H. Frederik, Sinnige, Harm, Schipperus, Martin, Schattenberg, Anton, van Marwijk Kooy, Marinus, Smit, Willem, Verhoef, Gregor, Chu, Isabel, Valk, Peter, Janssen, Jeroen JWM, Ossenkoppele, Gert

Volltext